43750 Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Notices

Chief, Cadastral Survey, Idaho State

Office, Bureau of Land Management,

1387 South Vinnell Way, Boise, Idaho,

83709–1657.

Dated: August 1, 1997.

Duane E. Olsen,

Chief Cadastral Surveyor for Idaho.

[FR Doc. 97–21689 Filed 8–14–97; 8:45 am]

BILLING CODE 4310–GG–M

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[NM–952–07–1420–00]

Notice of Filing of Plat of Survey; New

Mexico

AGENCY: Bureau of Land Management,

Interior.

ACTION: Notice.

SUMMARY: The plat of survey described

below will be officially filed in the New

Mexico State Office, Bureau of Land

Management, Santa Fe, New Mexico, on

September 5, 1997.

New Mexico Principal Meridian, New

Mexico:

Township 16 North, Range 7 East,

accepted August 4, 1997, for Group

942 NM.

If a protest against a survey, as shown

on the above plat is received prior to the

date of official filing, the filing will be

stayed pending consideration of the

protest. A plat will not be officially filed

until the day after all protests have been

dismissed and become final or appeals

from the dismissal affirmed.

A person or party who wishes to

protest against any of this survey must

file a written protest with the State

Director, Bureau of Land Management,

stating that they wish to protest.

A statement of reasons for a protest

may be filed with the notice of protest

to the State Director, or the statement of

reasons must be filed with the State

Director within thirty (30) days after the

protest is filed.

The above listed plat represents

dependent resurveys, surveys, and

subdivisions.

This plat will be available in the New

Mexico State Office, Bureau of Land

Management for public inspection, P.O.

Box 27115, Santa Fe, New Mexico

87502–0115. Copies may be obtained

from this office upon payment of $1.10

per sheet.

Dated August 5, 1997.

John P. Bennett,

Chief Cadastral Surveyor For New Mexico.

[FR Doc. 97–21642 Filed 8–14–97; 8:45 am]

BILLING CODE 4310–FB–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA #153F]

Controlled Substances: Revised

Aggregate Production Quotas for 1997

AGENCY: Drug Enforcement

Administration (DEA), Justice.

ACTION: Notice of final revised aggregate

production quotas for 1997.

SUMMARY: This notice establishes

revised 1997 aggregate production

quotas for controlled substances in

Schedules I and II of the Controlled

Substances Act.

EFFECTIVE DATE: August 15, 1997.

FOR FURTHER INFORMATION CONTACT:

Frank L. Sapienza, Chief, Drug and

Chemical Evaluation Section, Drug

Enforcement Administration,

Washington, D.C. 20537, Telephone:

(202) 307–7183.

SUPPLEMENTARY INFORMATION: Section

306 of the Controlled Substances Act

(21 U.S.C. 826) requires that the

Attorney General establish aggregate

production quotas for each basic class of

controlled substance listed in Schedules

I and II. This responsibility has been

delegated to the Administrator of the

DEA by § 0.100 of Title 28 of the Code

of Federal Regulations. The

Administrator, in turn, has redelegated

this function to the Acting Deputy

Administrator pursuant to § 0.104 of

Title 28 of the Code of Federal

Regulations.

On June 5, 1997, a notice of the

proposed revised 1997 aggregate

production quotas for controlled

substances in Schedules I and II was

published in the Federal Register (62

FR 30883). All interested parties were

invited to comment on or object to these

proposed aggregate production quotas

on or before July 7, 1997.

Several companies commented that

the revised 1997 aggregate production

quotas for amphetamine, difenoxin,

diphenoxylate, methadone intermediate,

N-ethylamphetamine, noracymethadol,

oxycodone, oxymorphone and

pentobarbital were insufficient to

provide for the estimated medical,

scientific, research and industrial needs

of the United States, for export

requirements and for the establishment

and maintenance of reserve stocks.

DEA has reviewed the involved

companies’ 1996 year-end inventories,

their initial 1997 manufacturing quotas,

1997 export requirements and their

actual and projected 1997 sales. Based

on this data, the DEA has adjusted the

revised 1997 aggregate production

quotas for difenoxin, diphenoxylate, Nethylamphetamine, noracymethadol,

oxycodone, oxymorphone and

pentobarbital to meet the estimated

medical, scientific, research and

industrial needs of the United States.

Regarding amphetamine and

methadone intermediate, the DEA has

determined that no adjustments of the

aggregate production quotas are

necessary to meet the 1997 estimated

medical, scientific, research and

industrial needs of the United States.

Based on recent data submitted by

two companies, DEA has adjusted the

revised 1997 aggregate production

quotas for hydromorphone and lysergic

acid diethylamide (LSD) to meet the

estimated medical, scientific, research

and industrial needs of the United

States.

The Office of Management and Budget

has determined that notices of aggregate

production quotas are not subject to

centralized review under Executive

Order 12866. This action has been

analyzed in accordance with the

principles and criteria contained in

Executive Order 12612, and it has been

determined that this matter does not

have sufficient Federalism implications

to warrant the preparation of a

Federalism Assessment.

The Acting Deputy Administrator

hereby certifies that this action will

have no significant impact upon small

entities whose interests must be

considered under the Regulatory

Flexibility Act, 5 U.S.C. 601 et seq. The

establishment of aggregate production

quotas for Schedule I and II controlled

substances is mandated by law and by

international treaty obligations.

Aggregate production quotas apply to

approximately 200 DEA registered bulk

and dosage from manufacturers of

Schedule I and II controlled substances.

The quotas are necessary to provide for

the estimated medical, scientific,

research and industrial needs of the

United States, for export requirements

and the establishment and maintenance

of reserve stocks. While aggregate

production quotas are of primary

importance to large manufacturers, their

impact upon small entities is neither

negative nor beneficial. Accordingly, the

Acting Deputy Administrator has

determined that this action does not

require a regulatory flexibility analysis.

Therefore, under the authority vested

in the Attorney General by section 306

of the Controlled Substances Act of

1970 (21 U.S.C. 826), delegated to the

Administrator of the DEA by § 0.100 of

Title 28 of the Code of Federal

Regulations, and redelegated to the

Acting Deputy Administrator pursuant

to § 0.104 of Title 28 of the Code of
Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Notices 43751

Federal Regulations, the Acting Deputy

Administrator hereby orders that the

revised aggregate production quotas for

1997 for the following controlled

substances, expressed in grams of

anhydrous acid or base, be established

as follows:

Basic class

Established

revised 1997

quotas

Schedule I

2,5-Dimethoxyamphetamine ................................................................................................................................................................ 15,200,100

2,5-Dimethoxy-4-ethylamphetamine (DOET) ....................................................................................................................................... 2

3-Methylfentanyl ................................................................................................................................................................................... 14

3-Methylthiofentanyl ............................................................................................................................................................................. 2

3,4-Methylenedioxyamphetamine (MDA) ............................................................................................................................................. 22

3,4-Methylenedioxy-N-ethylamphetamine (MDEA) .............................................................................................................................. 27

3,4-Methylenedioxymethamphetamine (MDMA) .................................................................................................................................. 7

3,4,5-Trimethoxyamphetamine ............................................................................................................................................................ 2

4-Bromo-2,5-Dimethoxyamphetamine ................................................................................................................................................. 2

4-Bromo-2,5-Dimethoxyphenethylamine (2-CB) .................................................................................................................................. 2

4-Methoxyamphetamine ....................................................................................................................................................................... 17

4-Methylaminorex ................................................................................................................................................................................. 2

4-Methyl-2,5-Dimethoxyamphetamine (DOM) ..................................................................................................................................... 2

5-Methoxy-3,4-Methylenedioxyamphetamine ...................................................................................................................................... 2

Acetyl-alpha-methylfentanyl ................................................................................................................................................................. 2

Acetylmethadol ..................................................................................................................................................................................... 7

Alpha-acetylmethadol ........................................................................................................................................................................... 7

Alpha-ethyltryptamine .......................................................................................................................................................................... 2

Alpha-methadol .................................................................................................................................................................................... 2

Alpha-methylfentanyl ............................................................................................................................................................................ 2

Alpha-methylthiofentanyl ...................................................................................................................................................................... 2

Aminorex .............................................................................................................................................................................................. 7

Beta-acetylmethadol ............................................................................................................................................................................ 2

Beta-hydroxyfentanyl ........................................................................................................................................................................... 2

Beta-hydroxy-3-methylfentanyl ............................................................................................................................................................ 2

Beta-methadol ...................................................................................................................................................................................... 2

Bufotenine ............................................................................................................................................................................................ 2

Cathinone ............................................................................................................................................................................................. 9

Codeine-N-oxide .................................................................................................................................................................................. 2

Difenoxin .............................................................................................................................................................................................. 21,000

Dihydromorphine .................................................................................................................................................................................. 7

Ethylamine Analog of PCP .................................................................................................................................................................. 5

Heroin .................................................................................................................................................................................................. 2

Lysergic acid diethylamide (LSD) ........................................................................................................................................................ 57

Mescaline ............................................................................................................................................................................................. 7

Methaqualone ...................................................................................................................................................................................... 17

Methcathinone ...................................................................................................................................................................................... 11

Morphine-N-oxide ................................................................................................................................................................................. 2

N-Ethylamphetamine ............................................................................................................................................................................ 251,000

N-Hydroxy-3,4-Methylenedioxyamphetamine ...................................................................................................................................... 2

N,N-Dimethyltryptamine ....................................................................................................................................................................... 7

Noracymethadol ................................................................................................................................................................................... 2

Norlevorphanol ..................................................................................................................................................................................... 2

Normethadone ..................................................................................................................................................................................... 7

Normorphine ........................................................................................................................................................................................ 7

Para-fluorofentanyl ............................................................................................................................................................................... 2

Pholcodine ........................................................................................................................................................................................... 2

Psilocin ................................................................................................................................................................................................. 2

Psilocybin ............................................................................................................................................................................................. 2

Tetrahydrocannabinols ......................................................................................................................................................................... 25,100

Thiofentanyl .......................................................................................................................................................................................... 2

Thiophene Analog of Phencyclidine .................................................................................................................................................... 5

Schedule II

1-Phenylcyclohexylamine ..................................................................................................................................................................... 10

1-Piperidinocyclohexanecarbonitrile (PCC) ......................................................................................................................................... 12

Alfentanil .............................................................................................................................................................................................. 9,300

Amobarbital .......................................................................................................................................................................................... 15

Amphetamine ....................................................................................................................................................................................... 3,137,000

Carfentanil ............................................................................................................................................................................................ 500

Cocaine ................................................................................................................................................................................................ 550,100

Codeine (for sale) ................................................................................................................................................................................ 53,140,000

Codeine (for conversion) ..................................................................................................................................................................... 19,679,000

Desoxyephedrine ................................................................................................................................................................................. 1,393,000

1,361,000 grams of levodesoxyephedrine for use in a non-controlled, non-prescription product and 32,000 grams for methamphetamine.

Dextropropoxyphene ............................................................................................................................................................................ 116,469,000
43752 Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Notices

Basic class

Established

revised 1997

quotas

Dihydrocodeine .................................................................................................................................................................................... 188,000

Diphenoxylate ...................................................................................................................................................................................... 2,247,000

Ecgonine (for conversion) .................................................................................................................................................................... 651,000

Ethylmorphine ...................................................................................................................................................................................... 12

Fentanyl ............................................................................................................................................................................................... 193,000

Glutethimide ......................................................................................................................................................................................... 2

Hydrocodone (for sale) ........................................................................................................................................................................ 13,891,000

Hydrocodone (for conversion) ............................................................................................................................................................. 1,769,000

Hydromorphone ................................................................................................................................................................................... 743,000

Isomethadone ...................................................................................................................................................................................... 12

Levo-alpha-acetylmethadol (LAAM) ..................................................................................................................................................... 356,000

Levomethorphan .................................................................................................................................................................................. 2

Levorphanol ......................................................................................................................................................................................... 12,000

Meperidine ........................................................................................................................................................................................... 9,843,000

Methadone (for sale) ............................................................................................................................................................................ 3,977,000

Methadone (for conversion) ................................................................................................................................................................. 364,000

Methadone Intermediate (for conversion) ............................................................................................................................................ 5,275,000

Methamphetamine (for conversion) ..................................................................................................................................................... 723,000

Methylphenidate ................................................................................................................................................................................... 13,824,000

Morphine (for sale) ............................................................................................................................................................................... 11,126,000

Morphine (for conversion) .................................................................................................................................................................... 68,165,000

Noroxymorphone (for sale) .................................................................................................................................................................. 30,000

Noroxymorphone (for conversion) ....................................................................................................................................................... 2,000,000

Opium .................................................................................................................................................................................................. 575,000

Oxycodone (for sale) ........................................................................................................................................................................... 8,323,000

Oxycodone (for conversion) ................................................................................................................................................................. 1,200

Oxymorphone ...................................................................................................................................................................................... 66,000

Pentobarbital ........................................................................................................................................................................................ 19,201,000

Phencyclidine ....................................................................................................................................................................................... 60

Phenmetrazine ..................................................................................................................................................................................... 2

Phenylacetone ..................................................................................................................................................................................... 10

Secobarbital ......................................................................................................................................................................................... 491,000

Sufentanil ............................................................................................................................................................................................. 1,000

Thebaine .............................................................................................................................................................................................. 9,325,000

Dated: August 11, 1997.

James S. Milford,

Acting Deputy Administrator.

[FR Doc. 97–21587 Filed 8–14–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF LABOR

Office of the Secretary

Submission for OMB Review;

Comment Request

August 12, 1997.

The Department of Labor (DOL) has

submitted the following public

information collection requests (ICRs) to

the Office of Management and Budget

(OMB) for review and approval in

accordance with the Paperwork

Reduction Act of 1995 (Pub. L. 104–13,

44 U.S.C. Chapter 35). A copy of each

individual ICR, with applicable

supporting documentation, may be

obtained by calling the Department of

Labor, Departmental Clearance Officer,

Theresa M. O’Malley ((202) 219–5096

ext. 143) or by E-Mail to O’MalleyTheresa@dol.gov. Individuals who use a

telecommunications device for the deaf

(TTY/TDD) may call (202) 219–4720

between 1:00 p.m. and 4:00 p.m. Eastern

time, Monday–Friday.

Comments should be sent to Office of

Information and Regulatory Affairs,

Attn: OMB Desk Officer for BLS, DM,

ESA, ETA, MSHA, OSHA, PWBA, or

VETS, Office of Management and

Budget, Room 10235, Washington, DC

20503 ((202) 395–7316), within 30 days

from the date of this publication in the

Federal Register.

The OMB is particularly interested in

comments which:

• Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

• Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

• Enhance the quality, utility, and

clarity of the information to be

collected; and

• Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Agency: Mine Safety and Health

Administration.

Title: Records of Preshift and Onshift

Inspections of Slope and Shaft Areas.

OMB Number: 1219–0082

(reinstatement without change).

Frequency: Twice per shift.

Affected Public: Business or other forprofit.

Number of Respondents: 30.

Estimated Time Per Respondent: 11⁄4

hours.

Total Burden Hours: 12,705.

Total Annualized capital/startup

costs: -0-.

Total annual costs (operating/

maintaining systems or purchasing

services): -0-.

Description: Requires coal mine

operators to conduct examinations of

slope and shaft areas for hazardous

conditions, including tests for methane

and oxygen deficiency, before and

during each shift and before and after

blasting. Records of the results of the

inspections are required to be kept.

Agency: Employment and Training

Administration.